Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...
The relative calm of a ceasefire between Israel and Hamas came to an abrupt end on Tuesday when Israel launched dozens of ...
Also Read: PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington ... Untreated phenylketonuria can lead to brain damage, intellectual disabilities, behavioral ...
and 70 Trump official unleashes new strategy to solve America's affordable housing crisis Jason Statham's ‘A Working Man' Leads Box Office With $15.2 Million, ‘Snow White' Collapses With 66% ...
Talks for extending ceasefire between Israel and Hamas continue amid backlash over US envoy’s direct engagement.
COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) ("Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...
Monterey County moves to recovery phase after Moss Landing ... Sanders signs massive 5-Year extension with Colorado | Speak Jason Statham's ‘A Working Man' Leads Box Office With $15.2 Million ...
We made significant progress in developing our two lead assets, BV100 and Alpibectir ... BioVersys plans for the initiation of the first global Phase 3 registration trial for BV100 in the second half ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
After months of debate about the validity of its phase 3 clinical trials for ... JPAD's editor-in-chief Dr Paul Aisen is one of the lead investigators on the Aduhelm (aducanumab) studies and ...
The stage is set for the highly anticipated 20th edition of the SEE Real Estate Awards, celebrating excellence in the dynamic Southeastern European property market. This prestigious event will take ...